Australia’s competition watchdog has moved Ampol’s proposed acquisition of EG Australia into a Phase 2 review under the country’s new mandatory merger regime.
Global Bioidentical Hormones Market to Expand at 6.19% CAGR as Demand for Customized Hormone Replacement and Age-Related Endocrine Care Accelerates.Austin, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results